Speakers
GF Securities Life Science Investment Conference will feature industry, regulatory and investment experts who have up-to-the-minute information on the life science industry in China. Confirmed speakers include:
Bob Ai, PhD, MBA - Senior Vice President, Trout Group
David Beier, JD - Partner, Bay City Capital
Zengjiang Cheng - Secretary-General, Tongxieyi
Fred Craves - Partner, Bay City Capital
Jianhua Ding - Director-General, Department of Drug and Cosmetics Registration, CFDA
Zhicheng Lin - CEO, By-Health
Jiarong Luo - Chief Analyst, GF Medicine
Rogers Luo - CEO, Gilead China
Dr. Richard M. Myers - Hudsonalpha Institute President and former Chair of Department of Genetics, Stanford University School of Medicine
Dr. Ruiqing Pei - Dean, Chinese Academy of Sciences, Guangzhou Institute of Biomedical and Health
Greg B. Scott - Founder and CEO of CinaBio Group
Yanchun, Wang - Chairman, Boji Pharmaceutical
Feng Wu - Vice President, Pfizer China
Xuesheng Xiao - GM, GF Xinde
Dr. Hao Zeng - Chairman, GF Xinde
More speakers will be added as confirmed.